Alcohol, a double-edged stimulant. Part 1: Metabolism and pathogenic effects of alcohol;Alkohol, ein zweischneidiges genussmittel. Teil1: Stoffwechsel und pathogene effekte von alkohol

Medizinische Monatsschrift fur Pharmazeuten

Volumn 35, Issue 8, 2012, Pages

  Ströhle, Alexander ^a   Wolters, Maike ^a   Hahn, Andreas ^a  

^a LEIBNIZ UNIVERSITY HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ALCOHOL METABOLISM; PATHOGENICITY; REVIEW;

EID: 84866300207     PISSN: 03429601     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (124)

1. Ahboucha S, Butterworth RF. The neurosteroid system: an emerging therapeutic target for hepatic encephalopathy. Metab Brain Dis 2007;22:291-308. (Pubitemid 47624317)
2. Ahboucha S, Butterworth RF. The neurosteroid system: implication in the pathophysiology of hepatic encephalopathy. Neurochem Int 2008;52:575-87.
3. Ahboucha S, Coyne L, Hirakawa R, Butterworth RF, et al. An interaction between benzodiazepines and neuroactive steroids at GABA-A receptors in cultured hippocampal neurons. Neurochem Int 2006;48:703-7.
4. Ajakaiye M, Jacob A, Wu R, Nicastro JM, et al. Alcohol and hepatocyte-Kupffer cell interaction (review). Mol Med Rep 2011;4:597-602.
5. Albrecht J, Zielinska M, Norenberg MD. Glutamine as a mediator of ammonia neurotoxicity: A critical appraisal. Biochem Pharmacol 2010;80:1303-8.
6. Alfonso-Loeches S, Guerri C. Molecular and behavioural aspects of the actions of alcohol on the adult and developing brain. Crit Rev Clin Lab Sci 2011;48:19-47.
7. Baliunas DO, Taylor BJ, Irving H, Roerecke M, et al. Alcohol as a risk factor for type 2 diabetes: A systematic review and meta-analysis. Diabetes Care 2009;32:2123-32.
8. Becker U, Deis A, Sorensen TIA, Gronbaek M, et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 1996;23:1025-102.
9. Bengtsson F. Brain tryptophan/serotonin perturbations in metabolic encephalopathy and the hazards involved in the use of psychoactive drugs. Adv Exp Med Biol 1999;467:139-54. (Pubitemid 32202154)
10. Blom HJ, Ferenci P, Grimm G, Yap SH, et al. The role of methanethiol in the pathogenesis of hepatic encephalopathy. Hepatology 1991;13:445-54.
11. Bode C, Bode JC. Protektive Wirkungen und Missbrauch von Alkohol. In: Biesalski HK, Fürst P, Kasper H, Kluthe R, Pölert W, et al. (Hrsg.). Ernährungsmedizin. 2. Auflage. Stuttgart: Thieme, 1999:516-38.
12. Brien SE, Ronksley PE, Turner BJ, Mukamal KJ, et al. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. BMJ 2011;342:d636 (doi: 10.1136/bmj.d636).
13. Burger M, Brönstrup A, Pietrzik K. Alkoholkonsum und Krankheiten. Schriftenreihe des Bundesministeriums für Gesundheit Band 134. Baden-Baden: Nomos, 2000.
14. Burger M, Brönstrup A, Pietrzik K. Derivation of tolerable upper alcohol intake levels in Germany: a systematic review of risks and benefits of moderate alcohol consumption. Prev Med 2004;39:111-27. (Pubitemid 38797962)
15. Cook CC, Hallwood PM, Thomson AD. B Vitamin deficiency and neuropsychiatric syndromes in alcohol misuse. Alcohol Alcohol 1998;33:317-36. (Pubitemid 28380025)
16. Cordoba J, Gottstein J, Blei AT. Glutamine, myo-inositol, and organic brain osmolytes after portocaval anastomosis in the rat: implications for ammonia-induced brain edema. Hepatology 1996;24:919-23. (Pubitemid 26334295)
17. Córdoba J, Mínguez B. Hepatic encephalopathy. Semin Liver Dis 2008;28:70-80. (Pubitemid 351326534)
18. Costanzo S, Di Castelnuovo A, Donati MB, Iacoviello L, et al. Wine, beer or spirit drinking in relation to fatal and non-fatal cardiovascular events: a meta-analysis. Eur J Epidemiol 2011;26:833-50.
19. Costanzo S, Di Castelnuovo A, Donati MB, Iacoviello L, et al. Alcohol consumption and mortality in patients with cardiovascular disease: a meta-analysis. J Am Coll Cardiol 2010;55:1339-47.
20. Cravo ML, Camilo ME. Hyperhomocysteinemia in chronic alcoholism: relations to folic acid and vitamins B6 and B12 status. Nutrition 2000;16:296-302. (Pubitemid 30176058)
21. Cubero FJ, Urtasun R, Nieto N. Alcohol and liver fibrosis. Semin Liver Dis 2009;29:211-21.
22. Cuevas A, Miquel JF, Reyes MS, Zanlungo S, et al. Diet as a risk factor for cholesterol gallstone disease. J Am Coll Nutr 2004;23:187-96. (Pubitemid 38746106)
23. Daniel H, Hahn A. Lebererkrankungen. Dtsch Apoth Ztg 1991;131: 469-78.
24. Davies MJ, Baer DJ, Judd JT, Brown ED, et al. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA 2002;287:2559-62. (Pubitemid 34517202)
25. Dejong CH, van de Poll MC, Soeters PB, Jalan R, et al. Aromatic amino acid metabolism during liver failure. J Nutr 2007;137(Suppl 1): 1579S-85S. (Pubitemid 46855512)
26. Dekanat W, Vamvakas S. Alkohole. In: Aktories K, Förstermann U, Hofmann B, Starke K. Allgemeine und spezielle Pharmakologie und Toxikologie. Begründet von W. Forth, D. Henschler und W. Rummel. 9. Auflage. München/Jena: Urban & Fischer, 2005:1041-50.
27. Denk H. Leber und intrahepatische Gallenwege. In: Böcker W, Denk H, Heitz PH-U. Pathologie. 2. Auflage. München/Jena: Urban & Fischer, 2001:701-44.
28. Deutsche Hauptstelle für Suchtfragen e. V. (Hrsg.). Jahrbuch Sucht. Geesthacht: Neuland, 2003.
29. Di Castelnuovo A, Costanzo S, Bagnardi V, Donati MB, et al. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med 2006;166:2437-45. (Pubitemid 44913227)
30. Di Castelnuovo A, Costanzo S, Donati MB, Iacoviello L, et al. Prevention of cardiovascular risk by moderate alcohol consumption: epidemiologic evidence and plausible mechanisms. Intern Emerg Med 2010;5:291-7.
31. Egberts EH. Therapie der hepatischen Enzephalopathie. Leber Magen Darm 1987;17:244,247-62,265-73.
32. Fedirko V, Tramacere I, Bagnardi V, Rota M, et al. Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol 2011;22:1958-72.
33. Ferreira MP, Weems MK. Alcohol consumption by aging adults in the United States: health benefits and detriments. J Am Diet Assoc 2008;108:1668-76.
34. Franke A, Teyssen S, Singer MV. Alcohol-related diseases of the esophagus and stomach. Dig Dis 2005;23:204-13. (Pubitemid 43325919)
35. Fuchs J. Alcoholism, malnutrition, vitamin deficiencies, and the skin. Clin Dermatol 1999;17:457-61. (Pubitemid 29412940)
36. Giacosa A, Adam-Blondon AF, Baer-Sinnott S, Barale R, et al. Alcohol and wine in relation to cancer and other diseases. Eur J Cancer Prev 2012;21:103-8.
37. Gillmann A, Gerharz CD, Müssig K. Diagnostik und Therapie der hepatischen Enzephalopathie. Dtsch Med Wochenschr 2012;137:29-33.
38. Gundling F, Seidl H, Löffler N, Strassen I, et al. Metabolische Störungen bei Leberzirrhose (Teil 1): Hepatische Osteopathie und Malnutrition. Aktueller Stand der Diagnostik und Therapie. Dtsch Med Wochenschr 2009;134:2461-4.
39. Gundling F, Seidl H, Löffler N, Strassen I, et al. Metabolische Störungen bei Leberzirrhose (Teil 2): Hepatogener Diabetes mellitus. Aktueller Stand der Diagnostik und Therapie. Dtsch Med Wochenschr 2010;135:22-4.
40. Hahn A, Ströhle A, Wolters M. Ernährung - Physiologische Grundlagen, Prävention, Therapie. 2. Auflage. Wissenschaftliche Verlagsgesellschaft Stuttgart, 2006.
41. Hamid A, Wani NA, Kaur J. New perspectives on folate transport in relation to alcoholisminduced folate malabsorption - association with epigenome stability and cancer development. FEBS J 2009;276:2175-91.
42. Häussinger D, Görg B. Interaction of oxidative stress, astrocyte swelling and cerebral ammonia toxicity. Curr Opin Clin Nutr Metab Care 2010;13:87-92.
43. Häussinger D, Laubenberger J, vom Dahl S, Ernst T, et al. Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterology 1994;107:1475-80.
44. Häussinger D, Schliess F. Pathogenetic mechanisms of hepatic encephalopathy. Gut 2008;57:1156-65.
45. Häussinger D. Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology 2006;43:1187-90. (Pubitemid 43980095)
46. Hilgard P, Gerken G. Hepatische Enzephalopathie. Med Klin (Munich) 2004;99:591-602. (Pubitemid 39403172)
47. Hilgier W, Law RO, Zielinska M, Albrecht J. Taurine, glutamine, glutamate, and aspartate content and efflux, and cell volume of cerebrocortical minislices of rats with hepatic encephalopathy: influence of ammonia. Adv Exp Med Biol 2000;483:305-12.
48. Hoyumpa AM. Mechanisms of vitamin deficiencies in alcoholism. Alcohol Clin Exp Res 1986;10:573-81. (Pubitemid 17226975)
49. Iawano Y. Physio-pathological effects of alcohol on the cardiovascular system: its role in hypertension and cardiovascular disease. Hypertens Res 2010;33:181-91.
50. Irving HM, Samokhvalov AV, Rehm J. Alcohol as a risk factor for pancreatitis. A systematic review and meta-analysis. JOP 2009;10:387-92.
51. Islami F, Fedirko V, Tramacere I, Bagnardi V, et al. Alcohol drinking and esophageal squamous cell carcinoma with focus on light-drinkers and never-smokers: a systematic review and meta-analysis. Int J Cancer 2011;129:2473-84.
52. Islami F, Tramacere I, Rota M, Bagnardi V, et al. Alcohol drinking and laryngeal cancer: overall and dose-risk relation - a systematic review and meta-analysis. Oral Oncol 2010;46:802-10.
53. Jayakumar AR, Panickar KS, Murthy ChR, Norenberg MD. Oxidative stress and mitogenactivated protein kinase phosphorylation mediate ammonia-induced cell swelling and glutamate uptake inhibition in cultured astrocytes. J Neurosci 2006;26:4774-84. (Pubitemid 44315317)
54. Joosten MM, Beulens JW, Kersten S, Hendriks HF. Moderate alcohol consumption increases insulin sensitivity and ADIPOQ expression in postmenopausal women: a randomised, crossover trial. Diabetologia 2008;51:1375-81.
55. Joosten MM, Chiuve SE, Mukamal KJ, Hu FB, et al. Changes in alcohol consumption and subsequent risk of type 2 diabetes in men. Diabetes 2011;60:74-9.
56. Joosten MM, Grobbee DE, van der A DL, Verschuren WM, et al. Combined effect of alcohol consumption and lifestyle behaviours on risk of type 2 diabetes. Am J Clin Nutr 2010;91:1777-83.
57. Key J, Hodgson S, Omar RZ, Jensen TK, et al. Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues. Cancer Causes Control 2006;17:759-70.
58. Kopelman MD, Thomson AD, Guerrini I, Marshall EJ. The Korsakoff syndrome: clinical aspects, psychology and treatment. Alcohol Alcohol 2009;44:148-54.
59. Leary T. Therapeutic value of alcohol, with special consideration of relations of alcohol to cholesterol, and thus to diabetes, to arteriosclerosis, and to gallstones. N Engl J Med 1931;205:231-42.
60. Leitzmann MF, Giovannucci EL, Stampfer MJ, et al. Prospective study of alcohol consumption patterns in relation to symptomatic gallstone disease in men. Alcohol Clin Exp Res 1999;23:835-41. (Pubitemid 29256570)
61. Leitzmann MF, Tsai CJ, Stampfer MJ, et al. Alcohol consumption in relation to risk of cholecystectomy in women. Am J Clin Nutr 2003;78: 339-47. (Pubitemid 39655242)
62. Lemberg A, Fernández MA. Hepatic encephalopathy, ammonia, glutamate, glutamine and oxidative stress. Ann Hepatol 2009;8:95-102.
63. Li Y, Yang H, Cao J. Association between alcohol consumption and cancers in the Chinese population - a systematic review and meta-analysis. PLoS One 2011;6:e18776 (doi:10.1371/journal.pone.0018776).
64. Lieber CS. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004;34:9-19. (Pubitemid 40163989)
65. Lieber CS. Nutrition in liver disorders and the role of alcohol. In: Shils ME, Shike M, Ross AC, Caballero B, et al. (eds.). Modern nutrition in health and disease. 10th edition. Baltimore/Philadelphia: Lippincott Williams & Wilkins,2006:1235-59.
66. Lieber CS. Relationships between nutrition, alcohol use, and liver disease. Alcohol Res Health 2003;27:220-31. (Pubitemid 40692072)
67. Liu B, Balkwill A, Roddam A, Brown A, et al.; Million Women Study Collaborators. Separate and joint effects of alcohol and smoking on the risks of cirrhosis and gallbladder disease in middle-aged women. Am J Epidemiol 2009;169:153-60.
68. Lozeva V, Montgomery JA, Tuomisto L, Rocheleau B, et al. Increased brain serotonin turnover correlates with the degree of shunting and hyperammonemia in rats following variable portal vein stenosis. J Hepatol 2004;40:742-8. (Pubitemid 38507353)
69. Lozeva-Thomas V. Serotonin brain circuits with a focus on hepatic encephalopathy. Metab Brain Dis 2004;19:413-20. (Pubitemid 39361197)
70. Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med 2009;360:2758-69.
71. Mandrekar P, Szabo G. Signalling pathways in alcohol-induced liver inflammation. J Hepatol 2009;50:1258-66.
72. Mantena SK, King AL, Andringa KK, Eccleston HB, et al. Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radic Biol Med 2008;44: 1259-72.
73. McKillop IH, Schrum LW. Role of alcohol in liver carcinogenesis. Semin Liver Dis 2009;29:222-32.
74. Meier P, Seitz HK. Effekte des Alkohols. Gibt es neben negativen auch positive Auswirkungen chronischen Alkoholkonsums? Med Klin (Munich) 2006;101:891-7. (Pubitemid 46152998)
75. Mpabanzi L, Olde Damink SW, van de Poll MC, Soeters PB, et al. To pee or not to pee: ammonia hypothesis of hepatic encephalopathy revisited. Eur J Gastroenterol Hepatol 2011;23:449-54.
76. Mukamal KJ, Rimm EB. Alcohol consumption: risks and benefits. Curr Atheroscler Rep 2008;10:536-43.
77. Mukamal KJ. Understanding the mechanisms that link alcohol and lower risk of coronary heart disease. Clin Chem 2012;58:664-6.
78. Nova E, Baccan GC, Veses A, Zapatera B, et al. Potential health benefits of moderate alcohol consumption: current perspectives in research. Proc Nutr Soc 2012:1-9.
79. O'Keefe JH, Bybee KA, Lavie CJ. Alcohol and cardiovascular health: the razor-sharp double-edged sword. J Am Coll Cardiol 2007;50: 1009-14. (Pubitemid 47348233)
80. Pai JK, Mukamal KJ, Rimm EB. Long-term alcohol consumption in relation to all-cause and cardiovascular mortality among survivors of myocardial infarction: the Health Professionals Follow-up Study. Eur Heart J 2012;33:1598-605.
81. Parry CD, Patra J, Rehm J. Alcohol consumption and non-communicable diseases: epidemiology and policy implications. Addiction 2011;106:1718-24.
82. Pinzani M, Rosselli M, Zuckermann M. Liver cirrhosis. Best Pract Res Clin Gastroenterol 2011;25:281-90.
83. Prakash R, Mullen KD. Mechanisms, diagnosis and management of hepatic encephalopathy. Nat Rev Gastroenterol Hepatol 2010;7:515-25.
84. Prosser RA, Mangrum CA, Glass JD. Acute ethanol modulates glutamatergic and serotonergic phase shifts of the mouse circadian clock in vitro. Neuroscience 2008;152:837-48.
85. Rehm J, Taylor B, Mohapatra S, Irving H, et al. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev 2010;29:437-45.
86. Rimm EB, Williams P, Fosher K, Criqui M, et al. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 1999;319:1523-8.
87. Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, et al. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ 2011;342:d671 (doi: 10.1136/bmj.d671).
88. Ryle PR, Thomson AD. Nutrition and vitamins in alcoholism. Contemp Issues Clin Biochem 1984;1:188-224.
89. Schellinger PD, Hartmann MK, Klingmann Ch, Meinck HM. Hepatische Enzephalopathie. Nervenarzt 2003;74:1078-87. (Pubitemid 38101110)
90. Schiff ER. Hepatitis C and alcohol. Hepatology 1997;26(Suppl 1): 39-42.
91. Schliess F, Görg B, Fischer R, Desjardins P, et al. Ammonia induces MK-801-sensitive nitration and phosphorylation of protein tyrosine residues in rat astrocytes. FASEB J 2002;16:739-41.
92. Schliess F, Görg B, Häussinger D. Pathogenetic interplay between osmotic and oxidative stress: the hepatic encephalopathy paradigm. Biol Chem 2006;387:1363-70. (Pubitemid 44691416)
93. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008;371:838-51. (Pubitemid 351323895)
94. Sechi G, Serra A. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol 2007;6:442-55. (Pubitemid 46551868)
95. Seitz H, Bühringer G. Empfehlungen des wissenschaftlichen Kuratoriums der DHS zu Grenzwerten für den Konsum alkoholischer Getränke. www.dhs.de/fileadmin/user-upload/pdf/dhs-stellungsnahmen/ Grenzwerte-Alkoholkonsum-Jul10.pdf (Zugriff am 10.03.2012)
96. Seitz HK, Lieber CS, Simanowski UA. Handbuch Alkohol, Alkoholismus, alkoholbedingte Organschäden. Stuttgart: Haug, 2000.
97. Seth D, Haber PS, Syn WK, Diehl AM, et al. Pathogenesis of alcohol-induced liver disease: classical concepts and recent advances. J Gastroenterol Hepatol 2011;26:1089-105.
98. Shawcross DL, Balata S, Olde Damink SW, Hayes PC, et al. Low myo-inositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia. Am J Physiol Gastrointest Liver Physiol 2004;287:G503-9. (Pubitemid 39096614)
99. Shepard BD, Tuma PL. Alcohol-induced alterations of the hepatocyte cytoskeleton. World J Gastroenterol 2010;16:1358-65.
100. Siegmund SV, Dooley S, Brenner DA. Molecular mechanisms of alcohol-induced hepatic fibrosis. Dig Dis 2005;23:264-74. (Pubitemid 43325926)
101. Skowronska M, Albrecht J. Alterations of blood brain barrier function in hyperammonemia: an overview. Neurotox Res 2012;21:236-44.
102. Sozio M, Crabb DW. Alcohol and lipid metabolism. Am J Physiol Endocrinol Metab 2008;295:E10-6.
103. Suárez I, Bodega G, Fernández B. Glutamine synthetase in brain: effect of ammonia. Neurochem Int 2002;41:123-42. (Pubitemid 34521686)
104. Tacke F, Weiskirchen R. Pathophysiologie der Leberfibrose. Aktuelle Aspekte und neue Ansätze für antifibrotische Therapien. Internist (Berl) 2010;51:21-9.
105. Tangermann A. The role of mercaptans in the pathogenesis of hepatic encephalopathy. In: Bengston F, Jeppson A, Almdal T, Vilstrup H (eds.). Progress in hepative encephalopathy and metabolic nitrogen exchange. Boca Raton: CRC Press, 1991:259-70 (Zitiert in [89]).
106. Tessari P. Protein metabolism in liver cirrhosis: from albumin to muscle myofibrils. Curr Opin Clin Nutr Metab Care 2003;6:79-85. (Pubitemid 40684621)
107. Thomson AD. Mechanisms of vitamin deficiency in chronic alcohol misusers and the development of the Wernicke-Korsakoff syndrome. Alcohol Alcohol Suppl 2000;35:2-7.
108. Tramacere I, Negri E, Bagnardi V, Garavello W, et al. A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 1: overall results and dose-risk relation. Oral Oncol 2010;46:497-503.
109. Tramacere I, Negri E, Pelucchi C, Bagnardi V, et al. A meta-analysis on alcohol drinking and gastric cancer risk. Ann Oncol 2012;23:28-36.
110. Tramacere I, Scotti L, Jenab M, Bagnardi V, et al. Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose-risk relation. Int J Cancer 2010;126:1474-86.
111. Turati F, Gallus S, Tavani A, Tramacere I, et al. Alcohol and endometrial cancer risk: a case-control study and a meta-analysis. Cancer Causes Control 2010;21:1285-96.
112. U. S. Department of Health and Human Services and U. S. Department of Agriculture. Part D Section 7: Alcohol. www.cnpp.usda.gov/Publications/ DietaryGuidelines/2010/DGAC/Report/D-7-Alcohol.pdf (Zugriff am 10.03.2012).
113. U. S. Department of Health and Human Services, U. S. Department of Agriculture. If you drink alcoholic beverages, do so in moderation. www.nal.usda.gov/fnic/dga/alcohol.htm (Zugriff am 10.03.2012).
114. van den Berg H, van der Gaag M, Hendriks H. Influence of lifestyle on vitamin bioavailability. Int J Vitam Nutr Res 2002;72:53-9. (Pubitemid 34186307)
115. Vliegenthart R, Oei HH, van den Elzen AP, van Rooij FJ, et al. Alcohol consumption and coronary calcification in a general population. Arch Intern Med 2004;164:2355-60. (Pubitemid 39532247)
116. Voican CS, Perlemuter G, Naveau S. Mechanisms of the inflammatory reaction implicated in alcoholic hepatitis: 2011 update. Clin Res Hepatol Gastroenterol 2011;35:465-74.
117. Wallner M, Hanchar HJ, Olsen RW. Low-dose alcohol actions on alpha4beta3delta GABAA receptors are reversed by the behavioral alcohol antagonist Ro15-4513. Proc Natl Acad Sci U S A 2006;103:8540-5. (Pubitemid 43838491)
118. Wang J, Wang H, Chen Y, Hao P, et al. Alcohol ingestion and colorectal neoplasia: a metaanalysis based on a Mendelian randomization approach. Colorectal Dis 2011;13:e71-8 (doi: 10.1111/j.1463-1318.2010.02530.x).
119. Wright G, Noiret L, Olde Damink SW, Jalan R. Interorgan ammonia metabolism in liver failure: the basis of current and future therapies. Liver Int 2011;31:163-75.
120. Zahr NM, Kaufman KL, Harper CG. Clinical and pathological features of alcohol-related brain damage. Nat Rev Neurol 2011;7:284-94.
121. Zakhari S. Overview: how is alcohol metabolized by the body? Alcohol Res Health 2006;29:245-54.
122. Zielinska M, Hilgier W, Law RO, Gorynski P, et al. Effects of ammonia and hepatic failure on the net efflux of endogenous glutamate, aspartate and taurine from rat cerebrocortical slices: modulation by elevated K+ concentrations. Neurochem Int 2002;41:87-93. (Pubitemid 34521681)
123. Thews G (Begr.), Mutschler E., Vaupel P, Schaible H-G. Anatomie, Physiologie, Pathophysiologie des Menschen. 6. Auflage. Stuttgart: Wissenschaftliche Verlagsgesellschaft Stuttgart, 2007.
124. Seitz HK, Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 2007;7:599-612. (Pubitemid 47106631)